Advancing Biological
Sensing Platforms
Biosense360 is a healthcare technology company developing biosensing platforms intended to support health monitoring, research, and future medical device applications. Our technologies are designed to enable the collection and analysis of biological signals using non‑invasive or minimally invasive approaches.
Technology Platforms
Biogum™
Biogum is a biosensing platform under development intended to measure glucose‑related signals. Evaluated for its potential to support metabolic health monitoring in research and clinical development settings.
Metabolic HealthNeodetect™
Early‑stage biomarker detection platform under research and development. Explored for its ability to detect cancer‑associated biomarkers for future clinical applications.
Oncology ResearchSkinlytic™
Skin analytics platform designed to measure parameters. Intended for research, wellness assessment, and future dermatological applications, subject to regulatory review.
Skin AnalyticsMedical Device Development
& Regulatory Strategy
Biosense360 is building a foundation for regulated medical device development. Our strategy includes regulatory pathway assessment, risk management per ISO 14971, design controls, verification and validation planning, and clinical evaluation where applicable.
- Regulatory pathway assessment
- Risk management per ISO 14971
- Design controls and QMS integration
- Verification and validation planning
About Biosense360
Biosense360 focuses on the research and development of sensing technologies that measure biological and physiological parameters. Our multidisciplinary team combines expertise in biomedical engineering, data analytics, and quality system design.
As we expand into regulated medical devices, our development activities are guided by applicable FDA regulations, ISO standards, and Good Design Practice principles.
Partner with
Biosense360
We are focused on intellectual property development, regulatory readiness, and strategic partnerships to support long‑term value creation. Contact us to learn more about our biosensing platforms.